In this text-based CE Snips activity, experts in the field review the burden and limitations of anti-VEGF injections in the management of patients with nAMD or DME, assess the role of tyrosine kinases in disease pathophysiology, and evaluate the latest visual and safety outcomes from clinical studies evaluating the sustained delivery of TKIs in patients with nAMD or DME.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
100% of listed courses are free
254 of 254 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- Infectious Disease
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Practice Management & Ethics
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Rhinology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Article / monograph / reference
- Credit · Up to 0.5 credits
- Commercial Support
-
ReleasedMar 31, 2026
-
Last day to claim creditMar 31, 2027 6 months left
-
PRIME Education, Inc. (PRIME®) Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease
-
Med Learning Group Optimizing Outcomes in nAMD: Evidence-Based Selection, Sequencing, and Durability Strategies with Next-Generation Anti-VEGF Therapies
-
Paradigm Medical Communications, LLC Innovations in Sustained Treatment of nAMD: An Update on TKI Therapies From ARVO 2026
-
Vindico Medical Education, LLC nAMD, DR, and DME: Reducing Treatment Burden With Long-Acting Drug Delivery Systems
-
Vindico Medical Education, LLC Making Sense of Emerging Retinal Therapies: Expert Perspectives and Clinical Implications
-
Vindico Medical Education, LLC Advances in Second-Generation Anti-VEGF Therapy for Retinal Disease
